marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-08-2024
Ironwood Pharmaceuticals Financial Ratios 2011-2024 | IRWD
Annual Financial Ratios Ironwood Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2094.9 | 36.0 | 3.4 | 15.3 | 86.9 | -6.0 | -16.5 | -20.9 | -7.7 | -9.4 | -5.1 | -15.8 | -19.1 |
P/S |
19.4 | 16.4 | 4.4 | 4.2 | 4.4 | 4.9 | 6.5 | 6.2 | 7.3 | 23.4 | 61.2 | 7.7 | 18.8 |
EPS |
-0.0 | 0.3 | 3.3 | 0.7 | 0.1 | -1.9 | -0.8 | -0.6 | -1 | -1.4 | -2.4 | -0.7 | -0.7 |
EV (Enterprise Value) |
2.18 B | 1.1 B | 1.19 B | 1.27 B | 2.19 B | 2.06 B | 2.4 B | 2.3 B | 1.36 B | 1.96 B | 1.57 B | 1.1 B | 1.25 B |
EBITDA per Share |
-6.07 | 1.63 | 1.44 | 0.91 | 0.798 | -0.615 | -0.686 | -0.279 | -0.512 | -1.15 | -2.07 | -0.577 | -0.562 |
EV/EBITDA |
5.0 | 10.8 | 17.1 | -20.7 | -21.5 | -49.7 | -16.7 | -12.0 | -6.2 | -16.5 | -20.5 | ||
PEG |
16.98 | -1.16 | -0.78 | -0.61 | -0.81 | -0.04 | -0.42 | 0.48 | 0.27 | 0.23 | -0.02 | -3.43 | -1.88 |
P/B |
4.8 | 1.6 | 1.6 | 2.9 | -20.0 | -8.7 | 195.8 | 25.6 | 11.6 | 20.2 | 36.6 | 8.0 | 11.3 |
P/CF |
12.4 | 6.4 | 6.9 | 9.7 | 528.7 | -21.4 | -18.6 | -13.2 | -9.9 | -11.2 | -4.9 | -13.8 | -14.6 |
ROE % |
0.31 | 7.49 | 87.22 | 169.50 | -23.06 | 143.79 | -1187.42 | -122.47 | -149.98 | -214.13 | -713.70 | -50.42 | -59.03 |
ROA % |
-0.23 | 4.44 | 46.89 | 18.99 | 5.34 | -85.04 | -19.31 | -11.51 | -23.04 | -56.85 | -97.80 | -31.59 | -31.03 |
ROCE % |
273.01 | 38.37 | 38.33 | 228.19 | 32.35 | -48.00 | -20.08 | -6.73 | -15.56 | -62.05 | -105.92 | -41.59 | -45.98 |
Current Ratio |
- | - | - | - | 7.5 | 2.2 | 4.7 | 4.2 | 6.5 | 4.8 | 5.6 | 3.4 | 2.6 |
DSO |
402.3 | 456.3 | 125.2 | 73.6 | 99.9 | 85.2 | 100.5 | 86.4 | 133.1 | 123.4 | 51.3 | 3.6 | 3.6 |
DIO |
- | - | - | 37.7 | 9.9 | - | 14.0 | 211.2 | - | 70.7 | 1122.2 | 2533.8 | - |
DPO |
- | - | - | 270.0 | 83.9 | 202.0 | 305.0 | 3459.1 | 261248.7 | 139.3 | 516.2 | 8217.6 | - |
Operating Cycle |
402.2 | 456.2 | 125.2 | 111.3 | 109.8 | 85.2 | 114.6 | 297.6 | 133.1 | 194.1 | 1173.4 | 2537.4 | - |
Cash Conversion Cycle |
402.2 | 456.2 | 125.2 | -158.7 | 25.9 | -116.7 | -190.4 | -3161.5 | -261115.7 | 54.8 | 657.2 | -5680.2 | - |
All numbers in USD currency
Quarterly Financial Ratios Ironwood Pharmaceuticals
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.01 | -0.03 | - | 0.1 | -6.84 | 0.3 | - | 0.33 | 0.24 | 0.25 | 0.25 | 0.34 | 2.42 | 0.25 | 0.27 | 0.22 | 0.16 | 0.02 | 0.31 | 0.13 | 0.08 | -0.38 | -0.1 | -1.14 | -0.32 | -0.29 | 0.08 | -0.22 | -0.3 | -0.36 | -0.09 | -0.23 | -0.15 | -0.09 | -0.09 | -0.33 | -0.34 | -0.24 | -0.27 | -0.3 | -0.44 | -0.38 | -0.43 | -0.51 | -0.57 | -0.87 | -0.41 | 0.44 | -0.38 | -0.34 | -0.07 | -0.21 | -0.19 | -0.19 |
EBITDA per Share |
- | 0.07 | - | - | - | 0.39 | - | 0.45 | 0.36 | 0.37 | - | 0.41 | 0.4 | 0.28 | - | 0.31 | 0.21 | 0.09 | - | 451 | 148 | -105 | - | -936 | -82.1 | -226 | - | -85.8 | -243 | -249 | - | -143 | -69.1 | 6.02 | - | -122 | -0.25 | -0.18 | - | -0.2 | -0.35 | -0.32 | - | -0.4 | -0.48 | -0.8 | - | 0.52 | -0.33 | -0.32 | - | -0.14 | -0.14 | -0.17 |
ROE % |
-7.95 | 298.08 | 308.03 | 316.54 | 329.80 | 30.45 | 22.97 | 29.79 | 30.91 | 100.41 | 129.15 | 191.30 | 236.62 | 200.39 | 169.50 | 49.21 | -27.89 | -81.30 | -23.06 | 36.15 | 147.08 | 185.40 | 143.79 | 258.62 | -158.12 | -632.33 | -1187.42 | -1330.38 | -1052.19 | -635.65 | -122.47 | -116.99 | -117.03 | -134.99 | -149.98 | -177.74 | -175.34 | -193.01 | -214.13 | -307.62 | -421.81 | -524.09 | -713.70 | -608.14 | -413.47 | -271.36 | -50.42 | -26.32 | -78.17 | -67.00 | -59.03 | -18.78 | -17.15 | -16.75 |
ROA % |
4.68 | -171.19 | -169.21 | -164.37 | -162.46 | 17.21 | 12.00 | 15.67 | 12.43 | 51.28 | 54.36 | 58.41 | 59.39 | 25.05 | 18.99 | 23.14 | 22.11 | 20.66 | 5.34 | -11.21 | -68.84 | -86.76 | -85.04 | -78.38 | -31.20 | -23.63 | -19.31 | -23.20 | -22.55 | -18.31 | -11.51 | -11.88 | -14.85 | -19.55 | -23.04 | -32.21 | -37.30 | -47.88 | -57.39 | -64.59 | -73.99 | -79.01 | -97.80 | -98.23 | -55.37 | -49.76 | -31.59 | -15.85 | -46.44 | -37.71 | -31.03 | -9.87 | -9.02 | -8.81 |
ROCE % |
-35.86 | 284.24 | 308.46 | 320.05 | 344.02 | 42.12 | 33.20 | 44.44 | 44.09 | 46.37 | 65.16 | 137.98 | 199.56 | 239.07 | 146.16 | 75.51 | -67.97 | -143.33 | -75.63 | -0.99 | 144.30 | 174.91 | 100.38 | -96.96 | -368.94 | -792.85 | -1016.96 | -1059.36 | -904.42 | -510.93 | -68.30 | -95.83 | -80.96 | -102.17 | -101.19 | -142.68 | -156.64 | -174.73 | -153.86 | -301.80 | -408.26 | -502.66 | -536.99 | -503.94 | -322.95 | -194.64 | -20.04 | -39.71 | -92.44 | -81.34 | -53.81 | -19.68 | -17.25 | -16.88 |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
62.9 | 122.5 | - | 97.7 | 99.7 | 107.7 | - | 55.0 | 56.2 | 120.5 | 102.7 | 110.7 | 103.8 | 131.7 | 114.0 | 128.6 | 148.8 | 108.3 | 19.9 | 7.8 | 10.1 | 21.4 | 14.7 | 29.2 | 23.6 | 15.9 | 3.1 | 3.4 | 4.5 | 3.6 | 1.0 | 1.3 | 1.6 | 2.6 | 4.9 | 6.7 | 9.5 | 4.6 | 0.0 | 0.1 | 0.1 | 1.6 | 9.3 | 9.5 | 4.8 | 13.6 | 1.6 | 0.4 | 2.9 | 2.0 | 0.2 | 0.6 | 0.6 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 13.2 | - | 116.9 | 5.2 | 28.4 | - | 11.6 | 31.5 | 42.7 | - | 11.0 | 19.1 | 156.0 | - | - | - | - | - | - | 27.7 | 37830.7 | - | 127.4 | 43.0 | 642.6 | - | 999.9 | 591.2 | 1069.1 | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 26.9 | 26.9 | 94.5 | - | 717.4 | 32.1 | 825.4 | - | 294.4 | 370.5 | 596.5 | - | 239.5 | 415.8 | 2892.2 | - | - | - | - | - | - | 96.2 | 69741.6 | - | 122.1 | 57.1 | 471.9 | - | 457.8 | 270.7 | 902.7 | - | - | - | - | - | - | - | - |
Operating Cycle |
62.9 | 122.5 | - | 97.7 | 99.7 | 107.7 | - | 55.0 | 56.2 | 120.5 | 102.7 | 110.7 | 103.8 | 131.7 | 114.0 | 128.6 | 148.8 | 121.5 | 19.9 | 124.7 | 15.3 | 49.8 | 14.7 | 40.8 | 55.1 | 58.6 | 3.1 | 14.4 | 23.6 | 159.7 | 1.0 | 1.3 | 1.6 | 2.6 | 4.9 | 6.7 | 37.2 | 37835.3 | 0.0 | 127.5 | 43.1 | 644.2 | 9.3 | 1009.4 | 596.0 | 1082.7 | 1.6 | 0.4 | 2.9 | 2.0 | 0.2 | 0.6 | 0.6 | - |
Cash Conversion Cycle |
62.9 | 122.5 | - | 97.7 | 99.7 | 107.7 | - | 55.0 | 56.2 | 120.5 | 102.7 | 110.7 | 103.8 | 131.7 | 114.0 | 101.6 | 121.8 | 26.9 | 19.9 | -592.7 | -16.8 | -775.6 | 14.7 | -253.6 | -315.4 | -537.8 | 3.1 | -225.1 | -392.2 | -2732.5 | 1.0 | 1.3 | 1.6 | 2.6 | 4.9 | 6.7 | -59.0 | -31906.3 | 0.0 | 5.3 | -13.9 | 172.3 | 9.3 | 551.6 | 325.4 | 179.9 | 1.6 | 0.4 | 2.9 | 2.0 | 0.2 | 0.6 | 0.6 | - |
All numbers in USD currency